amdoxovir 300 mg bid

DRUG2 trials

Sponsors

RFS Pharma, LLC

Conditions

Human Immunodeficiency Virus Infection

Phase 2

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

TerminatedNCT01737359

RFS Pharma, LLCHuman Immunodeficiency Virus Infection

Start: 2012-12-31End: 2013-03-31Updated: 2014-11-05

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

WithdrawnNCT01738555

RFS Pharma, LLCHuman Immunodeficiency Virus Infection

Start: 2013-04-30End: 2014-10-31Updated: 2013-03-29